Latest / Bloomberg Law / Trump Asks SEC to Review Quarterly Earnings Reports
Transcript
- 0:03Speaker 1: Welcome to the Bloomberg Law Podcast. I'm June Grosso. Every
- 0:07Speaker 1: day we bring you insight and analysis into the most
- 0:10Speaker 1: important legal news of the day. You can find more
- 0:13Speaker 1: episodes of the Bloomberg Law Podcast on Apple Podcasts, SoundCloud
- 0:18Speaker 1: and on Bloomberg dot com slash podcasts. Earlier today, President
- 0:22Speaker 1: Trump tweeted that he's asked the SEC to study ending
- 0:26Speaker 1: quarterly reporting for US businesses to quote allow greater flexibility
- 0:30Speaker 1: and save money. Morgan Stanley CEO James Gorman voice support
- 0:34Speaker 1: for the idea on Bloomberg Today. I think quotally reporting,
- 0:39Speaker 1: and to Budda bluntly, I think it's s and I
- 0:41Speaker 1: every third in weeks and by the way, quote has
- 0:43Speaker 1: come around with alarming frequency. Right, They've been trying to
- 0:47Speaker 1: get this thing to stop. But at least you know
- 0:49Speaker 1: this is one thing the Brits definitely have figured out
- 0:53Speaker 1: what the six months reporting. Joining me is Peggy Collins,
- 0:56Speaker 1: Bloomberg News US Investing team leader. So, Peggy, it seems
- 1:00Speaker 1: natural that corporations would welcome getting rid of two reports
- 1:03Speaker 1: a year. But what are the dangers? Well, A couple
- 1:06Speaker 1: of the dangers are that investors have less transparency, right,
- 1:10Speaker 1: So We've seen this in the news of late with
- 1:13Speaker 1: Elon Musk saying he might take Tesla private. And one
- 1:16Speaker 1: of the reactions that we've had from shareholders or shareholder
- 1:20Speaker 1: activists is that, well, you're not getting as much information
- 1:23Speaker 1: then in terms of what the company's earnings might be,
- 1:26Speaker 1: what their executive pay is to influence whether you buy yourself.
- 1:31Speaker 1: The other potential is that when companies are in the
- 1:33Speaker 1: dark more, there's more potential for them to do nefarious
- 1:38Speaker 1: things such as insider trading, for example, and for it
- 1:41Speaker 1: to be harder for people to spot, or for companies
- 1:45Speaker 1: to be more worried about doing it in the first place,
- 1:47Speaker 1: and because they might get caught. So what are some
- 1:51Speaker 1: of the less obvious advantages to corporations besides just not
- 1:56Speaker 1: the extra work. Well, I think, as you said, the
- 1:59Speaker 1: extra work and all so costs for smaller companies. A
- 2:02Speaker 1: number of the plates that we've heard is that with
- 2:04Speaker 1: all the regulation today and the requirements from the SEC
- 2:08Speaker 1: of reporting, that if you're a smaller company, that's a
- 2:11Speaker 1: big burden. And therefore there's more and more smaller companies
- 2:14Speaker 1: that say I'm not going to go public, I'm going
- 2:16Speaker 1: to stay private because I don't want to have to
- 2:18Speaker 1: do all those things. So that's one of the things
- 2:20Speaker 1: I think. Another point is that we've talked to some
- 2:23Speaker 1: people today. You said it could make financial analysts more
- 2:26Speaker 1: popular or valuable because they are supposed to be talking
- 2:30Speaker 1: to companies regularly, and so if the public has information
- 2:33Speaker 1: on a less frequent basis, they the financial analysts who
- 2:37Speaker 1: put out reports could be become more important. So, Peggy,
- 2:40Speaker 1: this was released by the White House to clarify President
- 2:44Speaker 1: Trump's tweet. It says the President is interested in examining
- 2:47Speaker 1: this issue on whether short term earnings reporting requirements for
- 2:51Speaker 1: public companies reduce incentives for them to engage in long
- 2:55Speaker 1: term investing in the United States, a part of the
- 2:58Speaker 1: administration's ongoing regulatory form efforts. So put in that context,
- 3:03Speaker 1: does that give you more insight into what he's looking for.
- 3:06Speaker 1: So that's something definitely that I've been hearing over the
- 3:08Speaker 1: last few years, covering a variety of investors and family
- 3:11Speaker 1: offices that invest in companies in the US that aren't public,
- 3:15Speaker 1: a lot of family owned businesses across the country, And
- 3:18Speaker 1: one of the things that we've heard repeatedly is that
- 3:21Speaker 1: companies are saying, you know, what if we're under this
- 3:23Speaker 1: pressure every quarter to hit certain numbers in order for
- 3:27Speaker 1: our shareholders and the stock price to be in the
- 3:29Speaker 1: limelight in a good way. That prevents us from sometimes
- 3:33Speaker 1: putting money into research and development efforts that would actually
- 3:36Speaker 1: benefit the company over the longer term. So I'm not
- 3:39Speaker 1: going to go public. I'm going to take some private
- 3:41Speaker 1: investment money so that way I can spend some more
- 3:44Speaker 1: money in the shorter term on the long term value
- 3:47Speaker 1: of building another plant or or doing some research on technology,
- 3:51Speaker 1: for example. The SEC has been reticent to make changes.
- 3:55Speaker 1: Where does it stand well? The Trump tweet this morning
- 3:59Speaker 1: would surprising for a lot of us, including me, um
- 4:03Speaker 1: and so people have asked, you know, how quickly could
- 4:06Speaker 1: they do something like this? My opinion is not very fast.
- 4:09Speaker 1: Most regulatory items, and certainly something that would be such
- 4:13Speaker 1: a sea change like this one take a long time
- 4:15Speaker 1: to go through. There's a lot of public comments and
- 4:18Speaker 1: studies and um and this might have to go through Congress,
- 4:21Speaker 1: so I think it would take a while to have
- 4:23Speaker 1: to happen. The SEC also has a lot on its
- 4:25Speaker 1: plate between Elon Musk and Tesla and all sorts of things.
- 4:29Speaker 1: The SEC is always busy, but it would it be
- 4:32Speaker 1: likely to initiate this kind of a fundamental change. I
- 4:38Speaker 1: think it's possible. We've seen this happened in other places
- 4:41Speaker 1: around the world. You played that clip from James Gorman,
- 4:43Speaker 1: and essentially what happened in the UK of late in
- 4:47Speaker 1: the last decade or so is that they switched to
- 4:49Speaker 1: a more six month model of reporting. There's mixed results
- 4:53Speaker 1: on what that has actually mean. In some cases companies
- 4:56Speaker 1: have actually continued to put out the same types of
- 4:59Speaker 1: information on a more regular basis than six months anyway,
- 5:02Speaker 1: But it is one of those things that it's possible.
- 5:05Speaker 1: There's precedence for it. There's certainly a lot of corporate
- 5:09Speaker 1: uh excitement around it, and we've seen President Trump say
- 5:14Speaker 1: things and actually get them done in some cases faster
- 5:16Speaker 1: than people expected and with less and less regulations. Who
- 5:19Speaker 1: knows what will happen. So just we have about a
- 5:21Speaker 1: minute here. What's your what's your opinion of it? It's
- 5:25Speaker 1: a good question. I think the first thing that came
- 5:27Speaker 1: to my mind being a journalist is that more information
- 5:31Speaker 1: is usually better than less. Um So I think you know,
- 5:34Speaker 1: I was a personal finance reporter for many years here
- 5:36Speaker 1: at Bloomberg before leading our investing coverage, and that was
- 5:39Speaker 1: the first thing that came to my mind that I
- 5:41Speaker 1: I usually deferred to the fact that if you have
- 5:43Speaker 1: more information and shareholders have more information on what a
- 5:46Speaker 1: company is doing, that it keeps them more accountable to
- 5:49Speaker 1: what It also helps you make a more informed decision
- 5:52Speaker 1: on whether to buy yourself. I think you'll have quite
- 5:55Speaker 1: a while before we actually get to that point if
- 5:57Speaker 1: we do. Thanks so much, Peggy. That's Peggy Collins for
- 6:00Speaker 1: burg News US Investing team leader. At a cabinet meeting yesterday,
- 6:08Speaker 1: President Trump addressed the continuing fight against opioid addiction in
- 6:11Speaker 1: the US, asking Attorney General Jeff Sessions to take legal action.
- 6:16Speaker 1: I'd also like to ask you to bring a major
- 6:20Speaker 1: lawsuit against the drug companies on opioid. Some states have
- 6:24Speaker 1: done it, but I'd like a lawsuit to be brought
- 6:27Speaker 1: against these companies that are really sending opioids at a
- 6:32Speaker 1: level that it shouldn't be happening. Joining me is Richard
- 6:36Speaker 1: Austin is a professor at the University of Kentucky Law School.
- 6:40Speaker 1: Richard drug makers are also already facing more than nine
- 6:44Speaker 1: hundred lawsuits by more than twenty five cities, states, counties,
- 6:48Speaker 1: and others over opioid addiction, most of those in federal court,
- 6:52Speaker 1: and the Trump administration has filed a request to join
- 6:55Speaker 1: settlement talks in the multi district litigation in Ohio. So
- 7:00Speaker 1: I have the Justice Department bring a separate suit. Well,
- 7:04Speaker 1: I think the theories that they would use are somewhat
- 7:09Speaker 1: different from, UH, the theories that the other plantiffs have
- 7:13Speaker 1: been bringing in in the litigation that you spoke of.
- 7:16Speaker 1: In particular, they are a variety of federal statutes that
- 7:20Speaker 1: the drug companies and when I say drug companies, I
- 7:23Speaker 1: mean manufacturers, distributors, and large scale retail sellers UH that
- 7:28Speaker 1: they may have violated some of these federal statutes UH
- 7:31Speaker 1: and so UH. And indeed, the federal government has brought
- 7:37Speaker 1: suits against most of these UH pharmaceutical companies and has
- 7:42Speaker 1: either one or has reached settlements that were very favorable
- 7:46Speaker 1: to them. So I'm guessing that they don't want to
- 7:50Speaker 1: get caught up in a settlement process that the global
- 7:54Speaker 1: settlement process, which is which is what would come out
- 7:56Speaker 1: of the multidistrict litigation. So if they're so, if there's
- 8:01Speaker 1: a global settlement process going on in the multi district
- 8:03Speaker 1: litigation and there's a federal separate federal lawsuit, would that
- 8:07Speaker 1: affect the settlement process? Well, not directly, of course. Um, realistically,
- 8:14Speaker 1: there's only so much money the drug companies have, so
- 8:17Speaker 1: to the extent that they pay some of that to
- 8:21Speaker 1: the federal government, there will be less left for the
- 8:24Speaker 1: other plaintiffs, assuming that there is a settlement. Now, what
- 8:29Speaker 1: about criminal proceedings by the Justice Department. Well, that's a
- 8:34Speaker 1: very real possibility because many of these federal statutes I
- 8:38Speaker 1: spoke of our criminal as well as civil UH and
- 8:42Speaker 1: UH and therefore there's the prospect there's some pretty substantial
- 8:46Speaker 1: criminal liability, even jail time theoretically, although of course you
- 8:50Speaker 1: can't put a corporation in jail, but you can put
- 8:52Speaker 1: their officers in jail. And that almost happened about ten
- 8:57Speaker 1: years ago with Perdue Farm and Oxyconton. They were charged
- 9:02Speaker 1: with uh mislabeling, which in that case meant that their
- 9:08Speaker 1: sales reps were telling doctors that making statements to doctors
- 9:13Speaker 1: that were um contradictory to what the labeling on the
- 9:18Speaker 1: product approved by the FDA set And they were ultimately
- 9:21Speaker 1: find about six d million dollars and there was serious
- 9:25Speaker 1: talk about the sending some of the top executives to jail,
- 9:29Speaker 1: and instead they were find very substantial amounts of money
- 9:33Speaker 1: as well on these criminal charges. What do you see
- 9:38Speaker 1: and what has history shown us about the effectiveness of
- 9:41Speaker 1: litigation as a tactic to fight drug abuse. Well, I
- 9:47Speaker 1: don't think the track record is very good, at least
- 9:49Speaker 1: not so far. Of course, they were the only things
- 9:53Speaker 1: we have to to compare this with is the tobacco
- 9:56Speaker 1: litigation of some fifteen years ago, if twenty years ago,
- 10:01Speaker 1: and that certainly resulted in a very large settlement that
- 10:04Speaker 1: went to the States, But I'm not sure people gave
- 10:07Speaker 1: up smoking UM. And indeed it was almost the devil's
- 10:11Speaker 1: bargain because now the states, at least that were parties
- 10:15Speaker 1: to that settlement, UM had a strong incentive not to
- 10:19Speaker 1: put the tobacco companies out of business, because that would
- 10:22Speaker 1: kill the goose that was laying the golden egg. UM.
- 10:26Speaker 1: As far as the present UM litigation is concerned, I'm
- 10:31Speaker 1: uh skeptical that it will have much of an effect.
- 10:37Speaker 1: It might, of course, drug companies might change their conduct
- 10:40Speaker 1: in response to the prospect of even more UM damage awards.
- 10:46Speaker 1: But in the past they've pretty much just taken it
- 10:50Speaker 1: as a cost of doing business, then moved on. Even
- 10:52Speaker 1: that very substantial uh fine that I've spoke of earlier,
- 10:56Speaker 1: six million dollars perdue, just blew it off. They paid
- 11:00Speaker 1: the money, and they went back to pretty much doing
- 11:02Speaker 1: what they've been doing before. So I don't know that
- 11:06Speaker 1: it would uh really address the problem very very much.
- 11:12Speaker 1: Only only a minute here on a topic that certainly
- 11:15Speaker 1: deserves a lot of consideration. But so is the answer
- 11:19Speaker 1: then in legislation, what's the best answer? Well, I think
- 11:23Speaker 1: that's certainly part of it. I think in addition, um
- 11:26Speaker 1: the federal government in particular is going to have to
- 11:29Speaker 1: um uh finance some programs to try to deal with
- 11:34Speaker 1: the addiction problem. Uh. You know, you've got perhaps as
- 11:37Speaker 1: many as two million people who are addicted, and they're
- 11:40Speaker 1: going to stay addicted, perhaps for the rest of their lives,
- 11:43Speaker 1: and so you can't just leave them out there. You
- 11:47Speaker 1: have to do something to help them, and there isn't
- 11:50Speaker 1: much available at the present time. And of course, giving
- 11:54Speaker 1: the states a lot of money doesn't mean they're going
- 11:56Speaker 1: to spend it on these kinds of programs. It's it's
- 11:59Speaker 1: it's it's a really serious problem. Almost seventy thousand Americans
- 12:03Speaker 1: died from opioid overdoses last year alone. Thanks so much
- 12:06Speaker 1: for joining us this conversation. Richard. That's Richard Austinus, professor
- 12:10Speaker 1: at the University of Kentucky Law School. Thanks for listening
- 12:13Speaker 1: to the Bloomberg Law Podcast. You can subscribe and listen
- 12:17Speaker 1: to the show on Apple podcast, SoundCloud, and on Bloomberg
- 12:20Speaker 1: dot com slash podcast. I'm June Brosso. This is Bloomberg